Home › Therapeutic areas › Neurology › CLN2 Batten Disease
CLN2 Batten Disease (1 companies)
Companies with an active program in CLN2 Batten Disease.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| LXEO | Lexeo Therapeutics | CardiovascularNeurology Rare | 1 | Phase 2 | $237M | 12 |
No companies match.